REGENXBIO  logo
REGENXBIO RGNX
$ 8.9 1.6%

Quarterly report 2024-Q2
added 08-01-2024

report update icon

REGENXBIO Deferred Revenue 2011-2024 | RGNX

Annual Deferred Revenue REGENXBIO

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
148 K 1.83 M 3.33 M 449 K - 600 K - - 127 K 153 K - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.33 M 127 K 948 K

Quarterly Deferred Revenue REGENXBIO

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
21 K 13 K 148 K 442 K 448 K 1.31 M 1.83 M 5.9 M - 3.33 M 3.33 M 395 K 395 K 395 K 449 K 449 K 449 K 449 K - - - 600 K 600 K 600 K 600 K 600 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
5.9 M 13 K 1.03 M